According to sources, Stockholm-based startup Neko Health has secured $260 million in Series B funding led by Lightspeed Venture Partners, bringing the company’s valuation to $1.8 billion. The funding will support Neko’s expansion into new markets, including the U.S., further development of its diagnostic technology, and the opening of additional clinics to meet surging demand.
Founded in 2018 by Daniel Ek, co-founder of Spotify, and Hjalmar Nilsonne, Neko Health focuses on preventative healthcare through advanced diagnostics. Its clinics use proprietary hardware and software to generate millions of health data points during a single £300 session. The system identifies risks for conditions such as skin cancer, metabolic syndrome, diabetes, and heart disease. Customers receive consultations and tailored follow-up recommendations, with 80% rebooking for annual scans.
Nilsonne explained that Neko’s vertically integrated model allows the company to develop its own devices, software, and clinical services, enabling rapid updates and improved diagnostics. The company recently acquired a sensor startup to enhance its data capture capabilities.
With a waitlist exceeding 100,000 people and clinics already operating in Stockholm and London, Neko aims to bring its innovative model to the U.S., where demand is particularly strong. Bejul Somaia from Lightspeed Venture Partners will join Neko’s board to support its mission of delivering affordable, high-quality preventative healthcare.
Featured image: Credit: Neko Health
